What it’s for
- Studied for sleep-related symptoms
Cannabinol, a cannabinoid sold in some sleep products.
Purpose, evidence and practical considerations.
One small trial reported fewer awakenings at a tested oral dose, without establishing faster sleep onset. Evidence and long-term safety remain limited, especially for mixed products.
Confidence: weak
Human safety data are limited. Drowsiness, impairment, interactions with alcohol or sedatives, product mislabeling, and THC contamination are practical concerns.
CBN is a minor cannabinoid with activity at cannabinoid receptors, but human pharmacology and dose-response data remain limited.
Regulatory status: cannabinoid product with legal and regulatory status varying by formulation and jurisdiction; not an FDA-approved sleep treatment
The evidence on this page does not automatically apply to:
How people use it, with their schedules, context and original sources.
at night during post-surgical elbow pain
post-surgical night pain
Amount and timing patterns reported in public protocols; these are observations, not instructions. Private and hidden usage is excluded.
These share a protocol with this intervention. This does not establish that they work together or are suitable alternatives.